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ABSTRACT 
As newly synthesized polypeptides emerge 
from the ribosome, it is crucial that they fold 
correctly. To prevent premature aggregation, 
nascent chains interact with chaperones that 
facilitate folding or prevent misfolding until protein 
synthesis is complete. Nascent polypeptide–
associated complex (NAC) is a ribosome-
associated chaperone important for protein 
homeostasis. However, how NAC binds its 
substrates remains unclear. Using native 
electrospray ionization MS (ESI MS), limited 
proteolysis, NMR and cross-linking, we analysed 
the conformational properties of NAC from 
Caenorhabditis elegans and studied its ability to 
bind proteins in different conformational states. 
Our results revealed that NAC adopts an array of 
compact and expanded conformations and binds 
weakly to client proteins that are unfolded, folded, 
or intrinsically disordered, suggestive of broad 
substrate compatibility. Of note, we found that this 
weak binding retards aggregation of the 
intrinsically disordered protHLQĮ-synuclein both in 
vitro and in vivo. These findings provide critical 
insights into the structure and function of NAC. 
Specifically, they reveal the ability of NAC to 
exploit its conformational plasticity to bind a 
repertoire of substrates having unrelated sequences 
and structures independently of actively translating 
ribosomes.  
 
 
Upon emerging from the ribosome, most 
proteins have to fold into a unique three-
dimensional structure in order to become 
biologically active. Finding the correct fold and 
avoiding misfolding and aggregation are major 
problems for polypeptide chains in the crowded 
cellular environment. This problem is exacerbated 
by the slow rate of synthesis compared with the 
rapid rate of folding of most proteins, which 
provides an opportunity for partially synthesised 
proteins to become trapped in misfolded or 
aggregation-prone states (1-3). Help is at hand by 
molecular chaperones: essential proteins found 
across all kingdoms of life which facilitate protein 
folding, unfolding and degradation, forming a 
network of interactions necessary for maintaining a 
healthy proteome (1). Some chaperones have the 
specific role of interacting with newly synthesised 
polypeptides to prevent intermolecular interactions 
that could result in aggregation (4-6). Two general 
groups of chaperones exist: those that interact with 
the ribosome and the nascent chain simultaneously, 
thereby controlling the early stages of folding (7), 
and those that are not involved until the complete 
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polypeptide has emerged from the ribosome exit 
tunnel (8).    
Ribosome-associated chaperones vary 
across species. Bacteria possess the well-
characterised trigger factor, a chaperone with a 
molecular cradle structure that captures polypeptide 
chains as they emerge from the ribosome (9,10). Its 
interior structure is lined with hydrophobic residues 
that provide multiple contact points for its unfolded 
protein substrates (11). Within eukaryotes, the 
chaperone network is more complex and consists of 
two systems: the ribosome-associated complex 
(RAC) (12,13) and the nascent polypeptide 
associated complex (NAC) (14,15). 
Whereas NAC is highly conserved across 
eukaryotes, archaea possess a NAC homodimer 
FRQVLVWLQJ RI WZR Į-subunits, while yeast and 
PDPPDOLDSRVVHVVDKHWHURGLPHUIRUPHGRIĮ- and 
E-NAC subunits (16). The overall sequence 
homology between WKHUHVLGXHĮ-NAC and the 
 UHVLGXH ȕ-NAC subunits is only 26 %. 
However, both subunits contain a highly conserved 
(41 % sequence identity) central NAC domain of 
approximately 61 residues (Figure 1a). X-ray 
crystal structures of truncated human NAC (Figure 
1b) show that the D- and E-NAC subunits associate 
through their six-VWUDQGHG ȕ-barrel-like central 
NAC domains, although the structure, function and 
interactions made by the N- and C-terminal 
domains of the D-NAC and E-NAC subunits remain 
unknown (17,18). Human heterodimeric NAC has 
been shown to be more stable than its homodimeric 
DVVHPEOLHV DQG LPSRUWDQWO\ KRPRGLPHUV RI Į-
1$& GR QRW IRUP LQ WKH SUHVHQFH RI ȕ-NAC, 
suggestive of a specific heterodimeric complex 
despite the close sequence homology of the central 
NAC domains (17).  
Į-1$& GLIIHUV IURP ȕ-NAC in that it 
contains a single ubiquitin-associated (UBA) 
domain that comprises the C-terminal 40 amino 
acids of the polypeptide chain (Figure 1a) (19). 
Although the role of this domain remains unclear, a 
NAC variant which lacks the UBA domain has been 
shown to be a more potent suppressor of protein 
aggregation in vivo suggesting a regulatory role for 
the UBA domain in the chaperone activity of the 
complex (20). Previous reports have also shown 
that NAC interacts with translating ribosomes 
reversibly in a 1:1 stoichiometry and, ZKLOHĮ-NAC 
forms contacts with both the ribosome and the 
QDVFHQWFKDLQLWLVWKHȕ-NAC subunit that mediates 
the dynamic interaction with the ribosome via the -
RRKKK- motif (residues 71-75 (Figure 1a)) in its 
N-terminal region (21-23). Previous studies have 
also shown that NAC is able to protect the emerging 
nascent chain from proteolysis, confirming its role 
in guarding nascent chains during their synthesis 
(24). Multiple functions have been suggested for 
NAC in vivo, including protection of nascent chains 
from proteolysis and regulation of apoptosis, and 
WKHUH LVDOVR HYLGHQFHRI DKRPRGLPHURIĮ-NAC 
bound to DNA and RNA, implying that NAC can 
take the role of a transcription factor (16). Recently, 
NAC depletion in C. elegans was shown to cause 
mistargeting of translating ribosomes to the 
endoplasmic reticulum (ER) membrane and 
mistranslocation of mitochondrial proteins into the 
ER. Loss of NAC activity also reduced the median 
lifespan of C. elegans by 10 days by means of 
inducing ER and mitochondrial stress (25). Despite 
its ubiquity and central importance in protein 
synthesis and folding, how NAC binds and 
chaperones its substrate proteins, however, 
remained unknown. 
Over the past twenty years, native mass 
spectrometry has become a powerful tool for the 
interrogation of non-covalent protein complexes 
and their interactions (26-31). Complimentary 
information can be obtained using hydrogen 
exchange MS (32), fast photochemical-oxidation of 
proteins (FPOP) (33), each combined with 
identification of the sites of modification using 
proteolysis followed by LC-MS/MS. Furthermore, 
native MS methods enable the structure, stability 
and conformation of proteins and their complexes 
to be investigated directly upon their ionisation into 
the gas phase (34-36) With the advancement of 
instruments and software it has also become 
possible to interrogate transient non-covalent 
interactions between proteins using MS-based 
techniques.  For example, chemical cross-linking 
can be used to provide residue-specific information 
about transiently interacting partners using 
sequencing of cross-linked products using LC-
MS/MS (37).  
Here we use ESI-MS combined with ion 
mobility spectrometry-mass spectrometry (ESI-
IMS-MS) to study the conformational properties of 
wild-type (WT) DE-NAC (WT-NAC) from C. 
elegans for the first time. We also use MS-based 
techniques to provide information about the 
structure, dynamics and interactions of WT-NAC 
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with potential substrates in different 
conformational states. In addition, the 
conformations of WT-NAC and the heterodimer 
laFNLQJ WKH 8%$ GRPDLQ ǻ8%$-NAC) are 
compared using ESI-IMS-MS to establish the effect 
of the UBA domain on conformational properties 
of NAC. It has been suggested that the UBA 
domain, which is attached WRWKHĮ-NAC subunit via 
a highly flexible 34-residue linker, may regulate the 
chaperone activity of NAC (20). In parallel, 
chemical cross-linking of complexes formed 
between WT-NAC and D-synuclein (a 140-residue 
intrinsically disordered protein (IDP)) (38,39) and 
the 87-residue bacterial immunity protein Im7, in 
its four helical native state and unfolded by creating 
the triple mutant (TM-Im7) L18AL19AL37A 
(40,41) were used to compare the interactions of 
WT-NAC with different protein substrates and to 
identify their binding sites. Combined with analysis 
of the NAC-D-synuclein complex using 1H-15N 
NMR, and assays of the effect of NAC binding on 
D-synuclein aggregation in vitro and in vivo, the 
results reveal that NAC bind substrates with very 
different sequence and structural properties, 
forming weak interactions in a dynamic complex 
independent of the presence of the UBA domain or 
actively translating ribosomes.  
 
Results  
ESI-MS reveals both compact and extended 
conformations of NAC 
The native ESI-mass spectrum of purified 
C. elegans NAC obtained in 100 mM ammonium 
acetate buffer at pH 6.9 is shown in Figure 2a. The 
spectrum confirms the presence of a heterodimer of 
Į-1$& DQG ȕ-NAC with a molecular weight of 
39,306 Da (theoretical mass = 39,304 Da). The 
spectrum shows the presence of at least two distinct 
SURWHLQFRQIRUPDWLRQVIRUWKHĮ/ȕ-NAC dimer: the 
most abundant species has 11+ to 13+ charges and is 
likely the most native-like conformer, with a second 
population being more highly charged (14+ to 22+), 
suggestive of more expanded conformations. NAC 
dimers (a2ȕ2 DQG D VPDOO DPRXQW RI WKH IUHH Į-
subunit (measured mass = 21,803 Da; theoretical 
PDVV 'DDQGȕ-subunit (measured mass 
= 17,504 Da; theoretical mass = 17,502 Da) were 
also visible in the spectrum. Control experiments 
using native PAGE showed only a single band 
(inset of Figure 2a) suggesting that some 
dissociation of the heterodimer alongside self-
association to larger species occurs in the gas-phase 
but does not occur in solution. Interestingly, native 
ESI-MS of the NAC construct lacking its UBA 
GRPDLQ ǻ8%$-NAC, measured mass = 35,091 
Da; theoretical mass = 35, 091 Da) showed the 
same distribution of charge states as WT-NAC, 
with the 12+ charge state ions being the most 
abundant species (Figure 2b), ruling out major 
conformational changes of the protein upon 
deletion of this domain.  
Native ESI-IMS-MS confirmed that 
species which have a range of compact and 
extended conformers of both WT-1$&DQGǻ8%$-
NAC exist in the gas-phase (Figure 2c, Supporting 
Information Table S1). The measured collision 
cross-sections (CCS) for the lowest observed (11+) 
charge states were 2962 ± 88 Å2 and 2761 ± 83 Å2 
for WT-NAC DQG ǻ8%$-NAC, respectively 
(Figure 2c). The function of the UBA domain 
within NAC has yet to be ascertained, but we 
hypothesised that the extended highly charged 
conformers of WT-NAC observed here using ESI-
MS could result from the attachment of the UBA 
domain to the NAC core via a flexible linker 
(Figure 1a). The ESI-IMS-MS results presented 
here rule out such a hypothesis, and show instead 
that the extended conformation observed for WT-
NAC is also observed for the protein lacking the 
UBA domain. Importantly, the finding that the 
difference in CCS of WT-1$&DQGǻ8%$-NAC is 
only ~200 Å2, consistent with the expected CCS of 
the folded UBA domain, confirms that NAC 
remains folded in the gas phase despite the lack of 
bulk solvent water (42,43)  
CD spectroscopy showed that WT-NAC 
contains 33% disorder, 27 % helical and 17% E-
stranded structure (Figure 2d and Supporting 
Information Table S1). Deletion of the 35-residue 
UBA domain resulted in a shift in the major peak 
IURPQP WRQPDQG WKHRYHUDOOĮ-helical 
content was reduced to ~15 %. This indicates the 
UBA domain makes a large contribution to the total 
Į-helical content of NAC, consistent with the 
known predominantly helical structure of the UBA 
domain (44). The proportion of unstructured 
protein was increased to 36 % in this variant 
compared with WT-NAC (Supporting Information 
Table S2).  
 
&,8LQGLFDWHV¨8%$-NAC is more susceptible to 
unfolding than WT-NAC 
Structure and function of NAC 
 
4 
To compare the stability of the WT-NAC and 
'UBA-NAC heterodimers in more detail the 
proteins were each examined using collision 
induced unfolding (CIU). The 12+ charge state ions 
for WT-1$&)LJXUHDDQGǻ8%$-NAC (Figure 
3b) were each isolated in the first (quadrupole) 
analyser of the ESI-MS-MS mass spectrometer and 
the collision energy increased step-wise in the trap 
cell prior to the IMS cell and second (time-of-flight) 
analyser. No dissociation of the heterodimers was 
observed at 10 V with drift times of 8.7 and 7.4 ms, 
respectively (Figure 3, lower panels). Clear 
differences in the unfolding patterns of the two 
proteins were observed, however, as the collision 
voltage was increased. For WT-NAC, a single 
conformation persisted at 25 V, with a second, more 
unfolded conformer (drift time 10.3 ms) becoming 
SRSXODWHG DW  9 %\ FRQWUDVW ǻ8%$-NAC 
showed evidence for substantial unfolding at 25 V, 
with the appearance of a second population (~40 % 
of molecules) with an arrival time of 9.1 ms in the 
IMS drift-time SORW)LQDOO\DW9ǻ8%$-NAC 
shows significant conformational rearrangements, 
with little, if any, residual population of native-like 
species with a drift time 7.8 ms. Instead a broad 
arrival time distribution (ATD) containing more 
highly expanded species results (Figure 3, top 
panel). The results presented here using far UV CD, 
ESI-IMS-MS and CIU together show that deletion 
of the UBA domain does not perturb the structure 
of the NAC heterodimer, but results in a complex 
that is more susceptible to unfolding in the dimeric 
state. This may result in a complex more able to 
bind its substrates, consistent with in vivo 
observations of an increased chaperone capacity of 
NAC upon deletion of the UBA domain (20). 
 
Limited proteolysis of WT-1$&DQG¨8BA-NAC 
Limited proteolysis followed by MS 
analysis of WT-1$& DQG ¨8%$-NAC was next 
carried out to investigate whether the presence of 
the UBA domain influences the accessibility of the 
Į- DQGȕ-domains to protease (Figure 4a,b). After 
incubation of NAC with trypsin (1:500 (w/w) 
trypsin:NAC) for 15 min at 20 ºC, a cleaved protein 
with a mass 2462 Da less than the native protein 
was observed (Figure 4a, lower). The population of 
this species became more intense relative to 
uncleaved NAC over time (data not shown). This 
mass loss from the native protein is consistent with 
SRVVLEOH ORVV RI 07*67(754.(9. Į-NAC 
residues 1-$'(4Į-NAC residues 158-161) 
DQG 0'6. ȕ-NAC residues 1-4) or 
07*67(754.(9.Į-NAC residues 1-13) and 
NETKAD(4ȕ-NAC residues 153-161). Notably 
WKHVDPHPDVVORVVZDVDOVRGHWHFWHGLQWKHǻ8%$-
NAC sample (Figure 4a, upper), indicating that 
these sequences are similarly accessible to protease 
in both heterodimers. In the low m/z range of the 
spectrum (m/z 800-1600), fragments corresponding 
to peptides from the N-WHUPLQDO UHJLRQRIĮ-NAC 
(e.g. 1-38, 9-38, 9-LQ:7Į-NAC and 1-38, 1-54 
and 2- RI ǻ8%$-NAC) and the C-terminal 
UHJLRQ RI ȕ-NAC (130-161 and 123-161 in WT-
1$& DQG ǻ8%$-NAC, respectively) were most 
abundant (Figure 4b). This indicates that these 
regions of the protein are most accessible to 
protease, while the core NAC regions, which form 
the dimer interface, remain uncleaved, as expected 
from their folded structure. These observations are 
consistent with the known domain architecture of 
the NAC complex (Figure 1a) and show that the 
UBA domain does not alter the accessibility of the 
protein complex to trypsin, although deletion of this 
domain decreases the stability of the complex to 
collision induced unfolding. 
 
Mapping NAC substrate interactions  
In order to identify residues required for 
substrate binding, WT-1$&DQGǻ8%$-NAC were 
each PL[HGLQDPRODUUDWLRZLWKĮ-synuclein (a 
140-amino acid IDP) (39) which was used as a 
model for unfolded polypeptide substrates as they 
may emerge from the ribosome. Despite exploring 
a wide range of instrumental conditions (increased 
backing pressure, increased trap cell pressure, 
decreased activation voltages) a complex was not 
observed using native ESI-MS. Nor was a complex 
observed via native PAGE (Figure 5a). However, 
iQFXEDWLQJĮ-synuclein in conditions in which it is 
aggregation-prone (125 µM protein, Dulbecco’s 
phosphate-buffered saline, 600 rpm agitation) with 
an equimolar concentration of WT-NAC prevented 
D-synuclein aggregation, at least over a timescale 
of 70 h (Figure 5b), suggesting that the proteins 
form a weak complex that cannot be maintained in 
the gas-phase, or on a native PAGE gel, but is 
sufficient to have a dramatic, protective effect on 
protein aggregation. To probe this NAC-client 
interaction further WT-NAC and D-synuclein were 
mixed and cross-linked using the homobifunctional 
amine cross-linker, BS3 (see Experimental 
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Procedures), and the samples examined by SDS-
PAGE to search for cross-linked products. Upon 
cross-linking WT-NAC alone, a band with the 
mobility expected for a cross-OLQNHG1$&ĮȕGLPHU
was observed (~45 kDa) (Figure 5c), consistent 
ZLWKWKHWKHRUHWLFDOPDVVRIDĮȕ-NAC dimer of 
~39 kDa. Weaker bands corresponding to NAC 
GLPHUV Į2ȕ2, DW a N'D WULPHUV Į3ȕ3, at ~150 
N'D DQG WHWUDPHUV Į4ȕ4, at ~200 kDa) were also 
visible (Figure 5c, leftmost lanes). Similar products 
were observed for 'UBA-NAC at lower molecular 
weight, consistent with deletion of the 4.2 kDa 
UBA domain (Figure 5c, rightmost lanes). 
Immediately following cross-linking, WT-NAC 
was also buffer exchanged into 100 mM 
ammonium acetate, pH 6.9 and the sample analysed 
by native ESI-MS. Interestingly, a significant 
decrease in the intensity of the charge state 
distribution for the extended conformation of NAC 
was observed in this sample, suggesting that the 
cross-linking has stabilised flexible regions of NAC 
such that they are no longer able to acquire as many 
positive charges (Figure S1).  
Cross-OLQNLQJĮ-synuclein and NAC mixed 
in a 1:1 molar ratio resulted in a new band observed 
by SDS-PAGE with a mobility of ~70 kDa (Figure 
5c, arrow) consistent with a 1:1 NAC-Į-synuclein 
complex. Importantly, there was no evidence for 
higher MW complexes, nor complexes involving 
>1 D-synuclein bound to WT-NAC or 'UBA-
NAC, indicating that a weak, but specific complex 
was formed. Consistent with this observation, 1H-
15N HSQC spectra of 15N-ODEHOOHG Į-synuclein in 
the presence or absence of one molar equivalent of 
WT-NAC showed small, but significant chemical 
shift perturbations for residues in the C-terminal 
~25 residues of the protein (Figure 6a, b)), 
suggestive that a specific, weak complex had 
formed. The C-WHUPLQDO UHJLRQ RI Į-synuclein is 
highly acidic, suggesting that electrostatic 
interactions between this region of D-synuclein and 
basic residues in NAC form at least part of the 
interaction interface.  Notably, a similar complex 
was formed, albeit at lower molecular weight, when 
D-synuclein was mixed with WKH ǻ8%$-NAC 
(Figure 5c, arrow), indicating that loss of the UBA 
GRPDLQ GRHV QRW SUHFOXGH 1$& IURP ELQGLQJ Į-
synuclein. The UBA domain, therefore, is not 
crucial for D-synuclein binding. 
To identify residues involved in forming 
the NAC-D-synuclein complex, an in-gel tryptic 
digest of the band arising from the putative complex 
was performed and LC-MS/MS was used to 
identify lysine residues that form intra- or inter-
molecular cross-links (Figure 5d and Supporting 
Information Tables S3-S5).  Many intermolecular 
cross-links were observed between D-NAC and E-
NAC (Supporting Information Table S3), 
especially involving their N-terminal domains 
(Figure 5d), suggestive of many, possibly transient, 
interactions between these regions. Only one cross-
link was observed between the N-terminal and C-
terminal domains of D-NAC, consistent with this 
complex being extended in nature with few 
interactions with the UBA domain (Figure 5d). 
Importantly, of the 8 lysines present in the DE-NAC 
core, only one intra-molecular cross link was 
observed between K84/K86 in D-NAC, consistent 
with the known crystal structure of the D/E-NAC 
core (PDB 3LKX) (18). K72 within D-NAC cross 
linked to the N-terminus of D-NAC, consistent with 
the known dynamics in this region. Furthermore, 
K82 within E-NAC reacted with BS3 but did not 
form cross-links, suggesting that this amino acid is 
solvent accessible but does not interact with client 
proteins or the adjacent lysine-rich ribosome 
binding motif within E-NAC (Supporting 
Information Table S3 & S6). These data are 
consistent with the view that the cross-links 
observed reflect specific interactions formed within 
the D/E NAC complex (Figure 5d). Interestingly, 
several cross-links were observed between the N- 
and C-terminal domains of E-NAC, suggesting that 
this subunit is more compact than the D-subunit in 
the NAC:substrate complex. An array of cross-links 
were observed between the N- and C-terminal 
domains of NAC and residues 1-102 of D-synuclein 
(Supporting Information Table S5). This 
interaction must also involve the acidic C-terminal 
region of D-synuclein revealed by NMR chemical 
shift perturbation (Figure 6b), although since this 
region lacks lysines no cross-links are observed. 
The absence of chemical shift perturbation in other 
regions of D-synuclein that do form cross-links to 
NAC is consistent with a diffuse binding interface 
in which the sidechain H-NH2 of lysine residues 
form transient, presumably electrostatic 
interactions with NAC, without perturbation of the 
chemical environment of the main-chain, 
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reminiscent of the binding of other ATP-
independent chaperones with their clients (9,45). 
Together, the results highlight the synergy of the 
MS and NMR approaches taken and confirm that 
NAC binds weakly to D-synuclein, forming 
transient interactions that are able to suppress its 
aggregation. 
To address the physiological relevance of 
our finding that NAC is able to suppress D-
synuclein aggregation in vitro, we used a transgenic 
C. elegans strain expressing D-synuclein fused to 
YFP (Figure 5e). By day 3 of adulthood these 
animals showed D-synuclein::YFP puncta. 
Strikingly, depletion of NAC by RNAi increased 
the number of D-synuclein puncta, showing that the 
presence of NAC also ameliorates D-synuclein in 
vivo. 
 
Does NAC interact with folded proteins? 
As NAC was shown to interact with an 
IDP, we next used native ESI-MS and chemical 
cross-linking to determine whether NAC can also 
bind folded proteins. For this, the  87-residue, four 
helical bacterial immunity protein Im7 was used 
(40), alongside its triple mutant (L18AL19AL37A; 
TM-Im7), which is trapped in an unfolded state 
(Figure 7a) (41). Im7 has been shown previously to 
fold in seconds (40) and hence could be considered 
as a mimic of a protein domain that folds rapidly 
upon emergence from the ribosome tunnel. By 
contrast, TM-Im7 was used as a model for an 
unfolded chain with an amino acid composition 
distinct from that of a highly charged and poorly 
hydrophobic IDP (46). Notably, both Im7 and TM-
Im7 have been shown previously to bind the ATP-
independent chaperone Spy (45). 
Cross-linking WT Im7 or TM-Im7 to NAC 
resulted in a unique band at ~60 kDa when analysed 
using SDS-PAGE suggesting that NAC can bind to 
Im7 in both its folded and unfolded states (Figure 
7b). No complex was observed using native ESI-
MS (not shown) indicating that the complex is too 
lowly populated, or too weak to survive passage 
into the gas-phase, as was also observed when NAC 
was mixed with D-synuclein. In-gel tryptic 
digestion of the bands and subsequent LC-MS/MS 
analysis, enabled two unique cross-links to be 
identified for the NAC-WT Im7 complex (Figures 
7c and Supporting Information Table S7). Two 
unique cross-links were also detected for the NAC-
TM-Im7 complex (Figure 7d, Supporting 
Information Table S10).  Again, the lack of higher 
order complexes, and the fact that only K79 of Im7 
formed detectable cross-links, despite having 7 
other solvent accessible lysine residues in each 
protein, supports the specificity of the cross-links 
observed. Interestingly, one of the cross-links 
identified, between the N-WHUPLQXVRIĮ-NAC and 
K79 of Im7, was the same in both samples. 
Additional cross-links from K79 of TM-Im7 to the 
C-terminal regiRQ RI ȕ-NAC were also observed. 
These data suggest, therefore, that NAC interacts 
with both folded and unfolded proteins using 
similar binding regions.  
 
Discussion 
Although many reports have suggested 
possible functions for NAC (16), much remains to 
be discovered about its structure and function. First 
identified in 1994 by Wiedmann et al. (47), NAC is 
now known to be crucial for protein folding and 
transport in the cell (25,48). Despite its importance 
as a chaperone, how NAC binds its client proteins, 
the role of different domains of NAC in client 
binding, and the nature of the substrate (whether 
folded, unfolded or intrinsically disordered) 
remained unknown. Here, we have used native ESI-
MS, limited proteolysis and cross-linking mapped 
by MS/MS, and combined these experiments with 
CD, NMR and aggregation assays in vitro and in 
vivo to characterise the conformational dynamics of 
1$&DQGLWVǻ8%$YDULDQW and to probe the nature 
of substrate recognition of NAC for three different 
model protein substrates. Native ESI-MS showed 
two different charge state distributions for NAC, 
suggesting WKDW WKH Įȕ-NAC heterodimer is 
dynamic in structure, visiting compact species as 
well as more extended states. Whilst care must be 
taken in interpreting the conformational properties 
of dynamic proteins by native MS, especially for 
unfolded chains and multi-domain proteins since 
collapse of the protein can occur in the gas phase 
(43), the observation that the termini of NAC are 
protease sensitive supports the view that these 
regions of the protein are dynamic and may unfold 
to give rise to the more extended species observed 
by ESI-MS. A similar array of charge states with 
similar drift times (taking the smaller mass of the 
complex into consideration) was also observed for 
WKHǻ8%$-NAC variant. Thus, the conformational 
dynamics observed cannot be attributed to the UBA 
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GRPDLQZKLFKLVNQRZQWREHFRQQHFWHGWRWKHĮ-
NAC domain via a flexible linker (20). This 
dynamic structure of NAC may be important for 
imparting its ability to bind a range of protein 
substrates, including both natively folded and 
unfolded structures, as shown here using native 
Im7, unfolded-TM Im7 and Į-synuclein as 
examples.  
Collision cross-sections determined using 
ESI-IMS-06 VKRZHG WKDW ǻ8%$-NAC has a 
reduced CCS compared with WT-NAC (Figure 2c). 
Based on the relationship between the molecular 
mass and CCS for globular proteins (49,50), WT-
NAC would be expected to have a CCS of ~2700 
Å2. The measured value of 2962 Å2 for WT-NAC 
is larger than this value, consistent with NAC 
containing flexible regions that contribute to the 
protein being more expanded than globular proteins 
of similar mass. A CCS of 2761 Å2 was measured 
IRUǻ8%$-1$&$Vǻ8%$-NAC is 4.2 kDa lower 
in molecular mass than WT-NAC, it would be 
expected to have a CCS reduced by ~200 Å2. The 
experimentally determined difference between the 
lowest charge state of WT-1$&DQGǻ8%$-NAC 
was 201 Å2 which indicates that the smaller mass is 
the main factor underlying the reduced CCS and not 
an altered conformation of the NAC heterodimer 
upon deletion of the UBA domain. 
$OWKRXJKERWK1$&DQGǻ8%$-NAC give 
rise to native ESI mass spectra with similar charge 
state distributions, these proteins have different 
stability in the gas-phase as indicated using CIU 
(Figure 3). These experiments showed that the 
absence of the UBA domain results in a complex 
that is more susceptible to unfolding in the dimeric 
state. We were unable to detect ubiquitin binding to 
NAC using native mass spectrometry (data not 
shown), and hence the role of the UBA domain in 
NAC remains unclear. Recently, Ott et al. 
GHPRQVWUDWHGWKDWǻ8%$-NAC is a better inhibitor 
of protein aggregation in QDFǻVVEǻ yeast cells, 
VXJJHVWLQJWKDWWKHǻ8%$-NAC heterodimer could 
have improved chaperone activity compared with 
the WT-NAC protein (20). 7KH IDFW WKDW ǻ8%$-
NAC formed an extended conformation at a lower 
collision energy than the WT-NAC suggests that 
this variant is more susceptible to undergoing 
conformational change which may, in part, 
rationalise the in vivo observations of improved 
chaperone activity. 
To determine whether NAC substrates are 
required to be unfolded such as those that remain 
unstructured as they emerge from the ribosome exit 
tunnel (22), or whether NAC can recognise 
structured domains such as those that fold rapidly 
upon emergence from the ribosome (51), we used 
chemical cross-linking coupled with LC-MS/MS to 
map the binding of NAC to two model proteins (D-
synuclein and Im7/TM-Im7) as potential substrates. 
The results showed that NAC binds weakly to the 
,'3Į-synuclein, as well as to Im7 in both its native 
and unfolded states. A weak interaction was 
supported by the small, but significant NMR 
chemical shift perturbations specifically involving 
the acidic C-terminal region of D-synuclein upon 
NAC binding. That this interaction is functionally 
relevant was demonstrated by the finding that NAC 
suppresses D-synuclein aggregation both in vitro 
and in vivo in C. elegans (Figure 5b, e). A recent 
study showed that although ribosome-WHWKHUHG Į-
synuclein is a weak substrate for trigger factor, this 
chaperone was observed to interact with the first 
110 N-terminal residues of the protein (52) 
Similarly, bindLQJRIĮ-synuclein and Im7/TM-Im7 
to NAC could not be detected by use of native ESI-
MS or native PAGE, consistent with a weak 
interaction. Such weak binding may be required for 
ATP-independent chaperones such as NAC, which 
rely on relatively rapid dissociation to enable 
substrate folding upon release (45,52-54). Overall, 
therefore, the results presented demonstrate that 
NAC can interact with both structured and 
disordered polypeptides, forming weak and/or 
transient interactions that predominantly involve 
the terminal domains of both the D- and E-subunits, 
at least for the model proteins used here. Whether 
these binding sites are specific for Im7/TM-Im7/D-
synuclein, or are utilised ubiquitously for other 
polypeptide chains remains to be seen. Moreover, 
the results presented indicate that attachment of 
NAC to the ribosome is not required for binding to 
the substrates used in this study. Ribosome binding 
could alter binding affinity and/or the kinetics of 
binding, and may alter the regions of NAC involved 
in substrate recognition. Indeed, the N-terminal 
domain of E-NAC may not be involved in substrate 
binding at the ribosome exit tunnel given that the -
RRKKK- motif in this domain is required for 
ribosome binding (Figure 1a) (21-23). Future work 
exploiting detailed NMR studies of these 
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complexes, combined with other experiments able 
to probe weak and transient complexes in residue-
specific detail (52) will now be needed to study the 
interactions of NAC with its clients in atomic detail. 
Similar studies of the same sequences when nascent 
on the ribosome (51,55) will then be able to reveal 
how the chaperone activity of NAC differs when 
on- and off- the ribosome. 
 
Experimental Procedures 
Experimental design and statistical rationale 
For CD experiments duplicate samples 
were analysed to ensure reproducibility. ESI-IMS-
MS, cross-linking and proteolysis experiments 
were performed at least in triplicate in separate 
experiments using freshly prepared samples. 
Controls included comparing NAC with and 
without substrate bound so as to reveal differences 
in conformation upon interaction. Details regarding 
search parameters and acceptance criteria for 
MS/MS are given below.  
 
NAC expression and purification 
BL21(DE3) Rosetta cells (Novagen, Merck 
(UK) Ltd., Watford, UK) were transformed with a 
plasmid encoding a His6-SUMO-NAC construct 
(25,48) which contains tandem hexahistidine and 
SUMO tags at the N-WHUPLQXVRIĮ-NAC. Bacteria 
were grown overnight on LB-agar plates 
supplemented with 100 µg/mL ampicillin and 25 
µg/mL chloramphenicol. A single colony was used 
to inoculate a 200 mL culture of LB medium 
containing 100 µg/mL ampicillin and 25 µg/mL 
chloramphenicol and incubated overnight at 30 °C 
with shaking at 120 rpm. The overnight culture was 
used to inoculate 6x1 L flasks of sterile LB 
containing 100 µg/mL ampicillin and 25 µg/mL 
chloramphenicol to an OD600 of 0.1. The cultures 
were incubated at 30 °C and 120 rpm shaking until 
an OD600 of 0.6-0.8 was reached (~3 h). Protein 
expression was induced by addition of 1 mM IPTG 
and incubation continued for 5 h after which time 
cells were harvested at 4,400 rpm and 4 °C for 20 
min (Beckman Avanti J-26 XP centrifuge, JLA 8.1 
rotor; Beckman Coulter (UK) Ltd., High 
Wycombe, Bucks, UK). Cells were resuspended in 
cold Buffer B1 (50 mM sodium phosphate buffer, 
300 mM NaCl, 6 mM MgCl2, 2 mM DTT, 2 mM 
PMSF, 10 % (v/v) glycerol, pH 8.0), harvested and 
the pellet stored at -80 °C. 
Cells were lysed using a French press 
(1100 psi) in Buffer B1 containing protease 
inhibitors and DNase (20 µg/mL) and then 
centrifuged at 16,000 rpm and 4 °C for 20 min 
(Sorvall SS34 rotor). 2.5 g of Protino Ni-IDA 
matrix (Macherey Nagel GmbH, Duren, Germany) 
was added to the lysate and incubated with agitation 
for 1 h at 4 °C. The matrix was then washed with 
50 mL of Buffer B1 containing 750 mM NaCl, 
followed by 50 mL of Buffer B1 where the 
concentration of NaCl was reduced to 25 mM. NAC 
was eluted from the matrix using Buffer B1 
supplemented with 250 mM imidazole and 
fractions containing NAC (as determined by SDS-
PAGE) were pooled and the concentration assessed 
using a Bradford assay. Ulp1(25,48) was added for 
SUMO-FOHDYDJHȝJHQ]\PHSHUPJRIVXEVWUDWH
and NAC was dialysed into Buffer B2 (20 mM 
sodium phosphate buffer, 25 mM NaCl,
 
6 mM 
MgCl2, 2 mM DTT, 5 % (v/v) glycerol, pH 7.4). 
The next day the NAC/Ulp1 mixture was loaded 
onto a Resource Q anion exchange column (6 mL 
column volume, GE Healthcare) that had been 
equilibrated with Buffer B2.  Proteins were eluted 
using an increasing gradient of high salt buffer 
(Buffer B3; 20 mM sodium phosphate buffer, 650 
mM NaCl,
 
6 mM MgCl2, 2 mM DTT, 5 % (v/v) 
glycerol, pH 7.4) over 25 column volumes and 
fractions of 1 mL were collected. Fractions 
FRQWDLQLQJERWKFOHDYHGĮ-1$&N'DDQGȕ-
NAC (17.5 kDa), as evaluated by SDS-PAGE, were 
pooled and dialysed overnight at 4 °C into Buffer 
B2. Aliquots were frozen in liquid N2 and stored 
and -80 °C. 
 
Į-Synuclein expression and purification 
Unlabelled and 15N-ODEHOOHG Į-synuclein 
were expressed recombinantly in E. coli BL21 
(DE3) cells and the protein purified as described 
previously (56). Cell pellets were resuspended in 
lysis buffer (25 mM Tris-+&OS+ȝJP/
O\VR]\PHȝJP/306)DQGȝJP/'1DVH
homogenised and then heated to 80 °C for 10 min. 
The homogenate was then centrifuged (35,000 x g, 
4 °C, 30 min) and the protein, isolated in the soluble 
fraction, was twice precipitated with 50 % (w/v) 
ammonium sulphate at 4 °C, 30 min. The pellet was 
resuspended in 20 mM Tris-HCl, pH 8.0 and loaded 
onto an anion exchange column (Q-Sepharose, GE 
Healthcare, Amersham, Bucks., UK), protein was 
eluted with a salt gradient. Final salt concentration 
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was 500 mM NaCl in 20 mM Tris-HCl, pH 8. Gel 
filtration (HiLoadTM 26/60 Superdex 75 
preparative grade gel filtration column using 20 
mM sodium phosphate, pH 7.5) was then used as a 
final purification step. Pure protein was dialysed 
against 50 mM ammonium bicarbonate and 
lyophilised.  
 
Im7 expression and purification  
Im7 constructs were over-expressed in E. 
coli and purified as described previously (40,41). 
Briefly, BL21 (DE3) cells transformed with chosen 
plasmid (containing WT Im7 or TM Im7 
(L18AL19AL37A) were cultured in LB medium 
with carbenicillin (100 µg/mL) selection at 37°C, 
200 rpm. Protein expression was induced using 1 
mM IPTG at an OD600= 0.6 and cells grown for a 
further 5 h. The bacteria were then harvested and 
lysed using sonication. Im7 proteins were then 
purified using Ni2+-affinity chromatography (Ni2+-
Sepharose column (5 mL volume) (GE Healthcare, 
Amersham, Bucks., UK)) using a gradient of 10-
500 mM imidazole in 50 mM Tris-HCl, 0.3 M 
NaCl, pH 8.0. Fractions containing Im7 were 
pooled, dialysed into 50 mM sodium phosphate 
buffer, pH 6.0 and purified further using ion-
exchange chromatography (Source15Q resin, 7 mL 
column (GE Healthcare, Amersham, Bucks., UK)) 
and gel filtration (300 mL Superdex-75 GL 
column) in the same buffer. Pure proteins were 
dialysed into 18 M: water and lyophilised. 
 
Native ESI-IMS-MS 
Samples were buffer exchanged into 100 
mM ammonium acetate (pH 6.9) using Micro Bio-
Spin™ size exclusion columns (Bio-Rad, Watford, 
UK). Native ESI-MS and ESI-IMS-MS 
experiments were performed on a Synapt HDMS 
mass spectrometer (Waters UK Ltd, Wilmslow, 
UK) operating in positive ionisation mode with the 
m/z range 500-8000 m/z calibrated with NaI 
dissolved in 50% (v/v) aqueous 2-propanol.  Protein 
solutions were diluted to 10 µM with ammonium 
acetate buffer and infused into the mass 
spectrometer using in-house prepared gold-plated 
borosilicate capillaries. Typically, an electrospray 
ionisation capillary voltage of 1.4-1.6 kV was 
applied with a source backing pressure of 4.0 mbar. 
The cone voltage was set to 40 V and the source 
temperature was maintained at 80 °C. Separation in 
the travelling-wave ion mobility cell was achieved 
using a wave velocity of 300 m/s and a ramped 
wave height from 4-12 V with an IMS gas flow 
(nitrogen) of 25 mL/min. For native MS 
experiments, the trap collision energy was 
maintained at 5 V. For collision-induced unfolding 
(CIU) experiments, the collision voltage was 
increased in 5 V increments up to 100 V. Data were 
processed using MassLynx v4.1 software and 
Driftscope v2.5 was used to extract arrival times 
from IMS-MS data. Arrival times were calibrated 
by measuring a series of standard proteins with 
known collision cross sections (CCS) under the 
same experimental conditions as described 
elsewhere (49). Raw mass spectrometry data is 
available at the following DOI: 
archive.researchdata.leeds.ac.uk/291/ 
   
Native PAGE 
10 % native gels were prepared in-house by 
adding 17 mL of dH2O to 10 ml of 30 % acrylamide 
(w/v) / 0.8 % (w/v) bisacrylamide and 3 mL of 10x 
Tris/glycine buffer (250 mM Tris-Cl, 1.94 M 
glycine, pH 8.5). Gels were polymerised by 
DGGLWLRQ RI  ȝ/  ZY DPPRQLXP
SHUVXOIDWH DQG  ȝ/ 7(0(' 6DPSOHV ZHUH
diluted 2-fold with loading buffer (50 mM Tris-Cl 
pH 8.6, 10 % (w/v) glycerol, 0.1 % (w/v) 
EURPRSKHQROEOXHDQGȝ/ORDGHGRQWRWKHJHO
alongside NativeMark™ unstained protein standard 
(Thermo Fisher Scientific). Gels were run at 250 V 
for 40 min, stained with 0.25% (w/v) Coomassie 
Blue/ 40 % (v/v) MeOH / 10 % (v/v) acetic acid for 
3 h and then destained in 40% (v/v) methanol / 10 
% (v/v) acetic acid overnight.   
 
Circular dichroism spectroscopy (CD) 
Far-UV circular dichroism (CD) spectra 
were recorded on a Chirascan CD 
spectrophotometer (Applied Photophysics, 
Leatherhead, Surrey, UK) using a 1 mm path length 
cuvette. Proteins were buffer exchanged into 
10 mM sodium phosphate buffer, pH 7.0 and 
measured at a protein concentration of 10 µM. 
Three scans were acquired over the range 190–
260 nm with a bandwidth of 2.5 nm and a scan 
speed of 1 nm/s. The three datasets were averaged 
and the buffer contribution subtracted to produce 
the final spectrum. Secondary structure content was 
estimated by uploading the data into DichroWeb 
(57) and using the CONTIN (58) algorithm. 
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Limited proteolysis 
NAC proteins were buffer exchanged into 
100 mM ammonium acetate (pH 6.9) and diluted to 
10 µM before adding trypsin at a 1:500 (w/w) 
protease:protein ratio (Sequencing Grade Modified 
Trypsin, Promega, UK Ltd., Southampton, UK). 
Mass spectra were measured after 15 min, 30 min 
and 1 h under the same conditions as described 
above for the native MS experiments. Fragments 
were assigned manually by comparison with 
theoretical digest peak lists obtained using the MS-
Digest tool in ProteinProspector v5.20.0 
(University of California, San Francisco, USA).  
The mass tolerance for precursor ions was 20 ppm 
and for fragment ions 10 ppm was employed. Raw 
mass spectrometry data is available at the following 
DOI: archive.researchdata.leeds.ac.uk/291/ 
   
Chemical cross-linking 
Substrate proteins were exchanged into 10 
mM sodium phosphate buffer, pH 7.0 and added to 
NAC at a 1:1 molar ratio (20 µM NAC + 20 µM 
substrate). 1 mg BS3-d0 and 1 mg BS3-d4 (bis-
(sulfosuccinimidyl) suberate) (Thermo Fisher 
Scientific, Altrincham, Cheshire, UK) were 
dissolved in 277 µL sodium phosphate buffer to 
produce a stock solution of 12.5 mM. The cross-
linker was then added to the proteins at 20-fold or 
50-fold molar excess and the reaction allowed to 
proceed at room temperature for 1 h before 
quenching by the addition of 50 mM Tris-HCl, pH 
7.5. Samples were analysed by Tris-tricine gels (15 
% (w/v) acrylamide, 0.4 % (w/v) bisacrylamide) 
followed by staining with InstantBlue™ 
(Expedeon, San Diego, CA, USA). Gel bands were 
excised from the gel, cut into 1 mm x 1 mm pieces 
and washed in 500 µL 25 mM ammonium 
bicarbonate, pH 7.8 for 1 h with shaking. The 
solution was removed and the pieces destained with 
100 µL 25 mM ammonium bicarbonate in 60 % 
(v/v) acetonitrile. This step was repeated three 
times. Gel pieces were then dehydrated with 100 % 
acetonitrile (v/v) for 10 min and left to air-dry in a 
laminar flowhood for 1 h. Rehydration of the gel 
pieces was achieved by adding 0.1 mg/mL trypsin 
in 25 mM ammonium bicarbonate and incubating 
the samples on ice for 30 min. Excess trypsin was 
then removed, 25 mM ammonium bicarbonate 
added to cover the gel pieces and the samples 
incubated at 37 °C with shaking (1000 rpm) 
overnight. Peptides were extracted from the gel 
using three washes with 60 % (v/v) acetonitrile / 5 
% (v/v) formic acid. The extracts were pooled and 
concentrated using a SpeedVac before being 
analysed using a ACQUITY UPLC M-Class 
coupled to a Synapt HDMS G2Si mass 
spectrometer (Waters UK Ltd., Wilmslow, UK). 
Peptides were injected onto a C18 column 
equilibrated with 0.1 % formic acid (v/v) in water 
and eluted using an increasing gradient of 0.1 % 
(v/v) formic acid in acetonitrile over 60 min at a 
flow rate of 0. 3 µL/min. The Synapt HDMS G2Si 
was operated in positive mode using a capillary 
voltage of 3.0 kV, cone voltage of 40 V, backing 
pressure of 3.6 mbar and a trap bias of 2.0 V. The 
source temperature was 80 °C and the trap pressure 
was 8.70 × 10í3
 mBar. Glu-fibrinogen and leucine 
enkephalin were infused as lock mass calibrants. 
Data acquisition was achieved using Data 
Dependent Analysis (DDA) with a one second MS 
scan over a m/z range of 250–3000 being followed 
by three 1 s MS/MS scans taken from the five most 
intense ions in the MS spectrum over a m/z range of 
50–2000. Data were acquired using MassLynx v4.1 
and processed using PEAKS Studio 7 
(Bioinformatics Solutions, Ontario, Canada). 
Cross-links were identified using StravroX 
software (59) and verified manually. Raw mass 
spectrometry data is available at the following DOI: 
archive.researchdata.leeds.ac.uk/291/ 
   
Analysis of cross-linking data 
Raw data files were acquired on a 
ACQUITY M-Class LC-MS coupled to a Synapt 
G2Si mass spectrometer. Data files (.raw) were 
imported into PEAKS Studio v8.0 for peptide 
identification from MS/MS data. An FDR of 1 % 
was applied. Data were exported as a Mascot 
Generic File (mgf) to be imported into 
StravroX3.6.0. FASTA files of each sequence were 
imported into StravroX and used to search for 
theoretical crosslinked peptides that were then 
compared to the experimental dataset. Threshold 
score/expectation value for accepting individual 
spectra was in line with StavroX guidelines. 
Trypsin was selected as the protease and 
crosslinking at K, S, T and Y residues were used as 
the search parameters. The decoy dataset was used 
to determine the score threshold above which 
crosslinked peptides had been assigned with 
confidence.  
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NMR spectroscopy 
1H-15N HSQC spectra were obtained using 
ȝ015N-ODEHOOHGĮ-synuclein in 10 mM sodium 
phosphate buffer, pH 7.2 containing 10 % (v/v) 
D2O. Spectra were acquired in the absence or 
presence of equimolar (unlabelled) NAC using a 
600 MHz NMR magnet (Oxford Instruments Plc, 
Abingdon, UK) with a room temperature probe and 
an Avance III HD console (Bruker UK Ltd., 
Coventry, UK). Data were processed and visualised 
using NMRPipe and CcpNMR analysis software 
(60). Assignments of 1H and HN atoms were 
transferred from the deposited chemical shifts in the 
Biological Magnetic Resonance Bank (ID:16543) 
(38). In cases where transferring assignments was 
difficult due to resonance overlap, the assignments 
were confirmed using HNCACB and HNCBCACO 
triple resonance spectra. Triple resonance spectra 
were acquired using DVDPSOHRIȝȂXQLIRUPO\
15N 13C labelled D-synuclein using a Varian Inova 
spectrometer performing at 600 MHz. Chemical 
shift differences were calculated using the formula; 
 ȟɁ =  ඥ(5 כ  ߜଵ ܪ)ଶ +  (ߜଵହ ܰ)ଶ 
 
ThT aggregation kinetics 
25 µL samples containing 125 µM D-
synuclein in Dulbecco’s phosphate buffered saline 
(Sigma-Aldrich, Irvine, UK, D8537), 0.02 % (w/v) 
sodium azide and 10 µM ThT were incubated at 37 
oC in sealed 384 well plates (Greiner bio-one Ltd, 
England) in a BMG Clariostar (BMG Labtech Ltd, 
England) plate reader using an excitation 
wavelength of 440r10 nm and emission 
wavelength of 475r10 nm, with agitation at 600 
rpm.  
 
Electron microscopy 
Transmission electron micrographs were 
acquired from the ThT aggregation assay samples 
using a JEM-1400 (JEOL Ltd) transmission 
electron microscope. Protein samples were pipetted 
onto carbon coated copper grids and stained with 1 
% (w/v) uranyl acetate solution.  
 
C. elegans strains and RNAi treatment 
 C. elegans was cultured according to 
standard techniques (61). Strain NL5901 (pkIs2386 
[unc-54p::alpha-synuclein::YFP + unc-119(+)] was 
obtained from the Caenorhabditis Genetics Center. 
RNAi was performed by feeding the worms with E. 
coli HT115(DE3) harbouring the vector L4440 to 
express dsRNA of the respective genes. 
Simultaneous knockdown of icd-1 and icd-2 was 
achieved as described previously (62). 
Immunoblot analysis and antibodies  
Protein samples were applied to bisTris–
PAGE and electro-blotted onto a nitrocellulose 
membrane according to standard protocols. 
Polyclonal antibody against C. elegans NAC 
(1:5000) was described previously (48). As a 
loading control, anti-actin (1:5000, Santa Cruz 
Bioctechnology) was used.  
Explanation of terms reported in cross-linking 
data tables 
Score = best score calculated for the 
crosslink within the two peptides. Crosslinked 
peptides with a score higher than the scores 
calculated from a decoy dataset (inverted 
sequences) are more probable. 
Abbreviation used: m/z = mass-to-charge 
ratio, z = peptide charge, M+H+= mass of singly 
charged precursor, Calculated = theoretical single 
charged mass of crosslinked peptide, Deviation = 
deviation of theoretical and experimental mass in 
ppm, Peptide 1/2 = Peptide sequence, Protein 1/2 = 
Protein that peptide is derived from, From/To = 
defines the start and stop position of peptide within 
the protein. 
Site = indicates the residue in the cross-
linked peptide that gave the best score  
Accession Codes 
D-NAC; >sp|Q86S66-2|1-195. E-NAC; 
>sp|Q18885|1-161. D-Synuclein; >sp|P37840|1-
140. Im7; >sp|Q03708|1-87. Im7 contains an 
additional His-tag (MEH6) for purification 
purposes which is not observed in Uniprot database. 
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Figure 1: Schematic representation of the nascent polypeptide associated complex (NAC). a) Domain 
VWUXFWXUHRIKXPDQ1$&KLJKOLJKWLQJWKH8%$GRPDLQRQĮ-NAC and the location of the ribosome binding 
motif (RRK-(X)n..RQȕ-NAC. b) DimerisDWLRQRIWKH1$&GRPDLQVZLWKĮ-1$&VKRZQLQEOXHDQGȕ-
NAC shown in purple (PDB 3LKX) (18). 
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Figure 2: Comparison of native ESI-mass spectra of WT-1$&DQGǻ8%$-NAC. Native ESI-mass 
spectra of a) WT-1$&DQGEǻ8%$-NAC. Each spectrum shows two charge state distributions for each 
heterodimer (green and red for WT-NAC and ¨UBA-NAC, respectively), with low populations of D2E2-
NAC dimers as indicated. In addition, low populations of dissociated D-NAC and E-NAC subunits are 
observed (blue). The insets show the proteins analysed by native PAGE which reveal a single band of the 
heterodimer and no evidence of dissociation. c) Estimated collision cross-sections (CCS) from ESI-IMS-
MS experiments for WT-1$& JUHHQ FLUFOHV DQG ǻ8%$-NAC (red triangles) show that compact and 
extended forms co-exist for both species (see also Supporting Information Table S1). d) Far UV CD spectra 
of WT-1$&JUHHQDQGǻ8%$-NAC (red). The secondary structure content obtained using CONTIN (58) 
is given in Supporting Information Table S2.  
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Figure 3: Collision induced unfolding (CIU)-IMS-MS for the 12+ charge state ions of WT-NAC and 
ǻ8%$-NAC. The quadrupole selected 12+ charge state ions are shown at a trap collision energy of 25 V 
for a) WT-1$&DQGEǻ8%$-NAC (left). Extracted ATDs for these charge states at 10 V, 25 V and 35 V 
are shown alongside. 
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Figure 4: Limited proteolysis of WT-1$&DQGǻ8%$-NAC followed by ESI-MS analysis. Each protein 
was treated with 1:500 (w/w) trypsin:substrate for 15 min at room temperature. a) Native ESI-MS shows a 
truncated complex with a reduced mass of 2,462 Da (blue peaks) and which remains assembled, is the first 
cleavage product for both WT-1$&DQGǻ8%$-NAC. b) Tryptic fragments observed in the low m/z range 
reveal a range of peptides released from the N-terminal domain of Į-NAC (blue) and from the C-terminal 
domain of E-NAC (orange). The same fragments are observed for WT-1$&DQGǻ8%$-NAC. Numbers 
denote the fragments within each NAC domain. Charge states resulting from the intact (undigested) NAC 
are shown in black. 
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Figure 5: ,QWHUDFWLRQVRIĮ-synuclein with WT-1$&DQGǻ8%$-NAC. a) Coomassie blue stained native 
polyacrylamide gel of Į-synuclein alone and mixed with an equimolar concentration of WT-NAC or 
'UBA-NAC, showing that a stable complex is not detected. b) Kinetic aggregation assays of Į-synuclein 
(125 µM, black), a 1:1 molar ratio RIĮ-synuclein with WT-NAC (purple), and WT-NAC alone (green) 
measured using ThT fluorescence. An equimolar concentration of WT-NAC WR Į-synuclein inhibits its 
aggregation over a 70 h timescale. Images alongside show negative stain transmission electron micrographs 
of the reaction endpoint (at 70 h) for each sample. Scale bar = 500 nm. c) SDS-PAGE analysis of cross-
linked WT-NAC and 'UBA-NAC PL[HGZLWKHTXLPRODUĮ-synuclein (a 50-fold excess of BS3 was used 
(Experimental Procedures)). 7KHDUURZVKLJKOLJKWWKHFRYDOHQWFRPSOH[EHWZHHQ1$&DQGĮ-synuclein. d) 
Map of cross-links between WT-NAC and Į-synuclein identified following in-gel tryptic digestion of the 
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band arrowed in (c). Intra-NAC or intra- Į-synuclein cross-links (purple), inter-NAC cross-links (green) 
and NAC-Į-synuclein cross-links (red). Peptides identified are listed in Supporting Information Tables 3-
5. e) RNAi-mediated NAC depleWLRQOHDGVWRLQFUHDVHGĮ-synuclein puncta formation in vivo. Fluorescence 
PLFURVFRSHLPDJHVRIWUDQVJHQLFZRUPVKHDGUHJLRQVDUHVKRZQH[SUHVVLQJĮ-synuclein::YFP in body-
ZDOOPXVFOHFHOOV:RUPVZHUHJURZQRQHPSW\YHFWRUFRQWUROHYRUĮȕ-NAC RNAi, respectively. Images 
were taken at day 1 and day 3 of adulthood. Scale bar  ȝP,QVHWZHVWHUQEORWVKRZV NAC protein 
expression levels, at indicated time points, by immunoblotting. Immunoblot against actin served as loading 
control.  
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Figure 6: 1H-151+64&VSHFWUDRIĮ-synuclein following addition of WT-NAC. a) Spectra are overlaid 
RIȝ015N-ODEHOOHGĮ-synuclein alone (black) and in the presence of 1 mol. equivalent of WT-NAC (red). 
Resonances which shift upon the addition of NAC are indicated with an arrow. b) Chemical shift 
SHUWXUEDWLRQVLQĮ-synuclein upon NAC binding. Residues exhibiting a significant chemical shift difference 
(> 1 standard deviation over the mean (dashed line)) are highlighted in red. 
 
 
 
Figure 7: NAC binds WT Im7 and TM Im7. a) Far UV CD spectra of WT Im7 (blue) and TM-Im7 
(orange) under the conditions used for the cross-linking experiments (see Experimental Procedures). b) 
SDS-PAGE analysis of NAC cross-linked alone (green) or to WT Im7 (blue) or TM-Im7 (orange) using 
BS3. Lanes show the addition of a 20x or 50x excess of BS3. The red arrow highlights the putative complex 
between NAC and the protein substrates. c) Map of the cross-links identified following in-gel tryptic digest 
of the putative NAC-Im7 complex: intra-NAC cross-links (purple), inter-NAC cross-links (green) and 
NAC-WT Im7 cross-links (red). d) Map of the cross-links identified following in-gel tryptic digest of the 
putative NAC-TM-Im7 complex band coloured as in (c).  Peptides identified are listed in Supporting 
Information Tables S6-S10.   
 
 
 
 
 
 
 
